QIC BioVentures
15
6M
8
0.79
4
0.47
1
- Stages of investment
- Areas of investment
Summary
In 2002 was created QIC BioVentures, which is appeared as VC. The main office of represented VC is situated in the Brisbane. The fund was located in Australia.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the QIC BioVentures, startups are often financed by GBS Ventures, Uniseed Ventures, Westscheme Pty Limited. The meaningful sponsors for the fund in investment in the same round are GBS Ventures, Uniseed Ventures, Westscheme Pty Limited. In the next rounds fund is usually obtained by GBS Ventures, Uniseed Ventures, OneVentures.
The common things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2005. This QIC BioVentures works on 22 percentage points less the average amount of lead investments comparing to the other organizations. Speaking about the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2016.
The fund has exact preference in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Medical Device, Biotechnology. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - Australia. Among the most popular portfolio startups of the fund, we may highlight Gelesis, Columna, Hatchtech.
Investments analytics
Analytics
- Total investments
- 15
- Lead investments
- 4
- Exits
- 1
- Rounds per year
- 0.79
- Follow on index
- 0.47
- Investments by industry
- Biotechnology (14)
- Medical (6)
- Therapeutics (5)
- Biopharma (5)
- Health Care (4) Show 9 more
- Investments by region
-
- Australia (12)
- United States (3)
- Peak activity year
- 2005
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Group Appearance index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Gelesis | 03 Jan 2008 | Biotechnology, Health Care, Medical Device, Diabetes | Early Stage Venture | 16M | United States, Boston, Massachusetts |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.